145 related articles for article (PubMed ID: 9436031)
21. [The animal research of recombinant adenovirus controlled by human telomerase reverse transcriptase promoter in the treatment of human prostate cancer].
Zhang Y; Qi JC; Lian WF; Cai WQ; Li W; Liu KL
Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(18):1252-5. PubMed ID: 17147886
[TBL] [Abstract][Full Text] [Related]
22. Transcription-targeted gene therapy for androgen-independent prostate cancer.
Martiniello-Wilks R; Tsatralis T; Russell P; Brookes DE; Zandvliet D; Lockett LJ; Both GW; Molloy PL; Russell PJ
Cancer Gene Ther; 2002 May; 9(5):443-52. PubMed ID: 11961667
[TBL] [Abstract][Full Text] [Related]
23. Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancer.
Shirakawa T; Gotoh A; Zhang Z; Kao C; Chung LW; Gardner TA
Urology; 2004 Mar; 63(3):613-8. PubMed ID: 15028478
[TBL] [Abstract][Full Text] [Related]
24. Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas.
Kaliberov SA; Kaliberova LN; Buchsbaum DJ
Gene Ther; 2005 Mar; 12(5):407-17. PubMed ID: 15616600
[TBL] [Abstract][Full Text] [Related]
25. A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors.
Kraaij R; van der Weel L; de Ridder CM; van der Korput HA; Zweistra JL; van Rijswijk AL; Bangma CH; Trapman J
Prostate; 2007 Jun; 67(8):829-39. PubMed ID: 17394196
[TBL] [Abstract][Full Text] [Related]
26. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
Matsubara S; Wada Y; Gardner TA; Egawa M; Park MS; Hsieh CL; Zhau HE; Kao C; Kamidono S; Gillenwater JY; Chung LW
Cancer Res; 2001 Aug; 61(16):6012-9. PubMed ID: 11507044
[TBL] [Abstract][Full Text] [Related]
27. In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter.
Pramudji C; Shimura S; Ebara S; Yang G; Wang J; Ren C; Yuan Y; Tahir SA; Timme TL; Thompson TC
Clin Cancer Res; 2001 Dec; 7(12):4272-9. PubMed ID: 11751529
[TBL] [Abstract][Full Text] [Related]
28. Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A gene.
Pang S
Cancer Gene Ther; 2000 Jul; 7(7):991-6. PubMed ID: 10917201
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer.
Shariat SF; Desai S; Song W; Khan T; Zhao J; Nguyen C; Foster BA; Greenberg N; Spencer DM; Slawin KM
Cancer Res; 2001 Mar; 61(6):2562-71. PubMed ID: 11289132
[TBL] [Abstract][Full Text] [Related]
30. Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy.
Li X; Liu YH; Lee SJ; Gardner TA; Jeng MH; Kao C
Clin Cancer Res; 2008 Jan; 14(1):291-9. PubMed ID: 18172281
[TBL] [Abstract][Full Text] [Related]
31. Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer.
Hall SJ; Mutchnik SE; Yang G; Timme TL; Nasu Y; Bangma CH; Woo SL; Shaker M; Thompson TC
Cancer Gene Ther; 1999; 6(1):54-63. PubMed ID: 10078964
[TBL] [Abstract][Full Text] [Related]
32. Highly specific expression of luciferase gene in lungs of naïve nude mice directed by prostate-specific antigen promoter.
Li HW; Li J; Helm GA; Pan D
Biochem Biophys Res Commun; 2005 Sep; 334(4):1287-91. PubMed ID: 16043123
[TBL] [Abstract][Full Text] [Related]
33. [Gene therapy].
Gotoh A; Shirakawa T; Wada Y; Hinata N; Terao S; Hara I; Arakawa S; Kamidono S; Okada H; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2005 Feb; 51(2):75-9. PubMed ID: 15773357
[TBL] [Abstract][Full Text] [Related]
34. [Prostate cancer gene therapy].
Nasu Y; Kumon H
Nihon Rinsho; 2005 Feb; 63(2):335-8. PubMed ID: 15714988
[TBL] [Abstract][Full Text] [Related]
35. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy for prostate cancer by targeting poly(ADP-ribose) polymerase.
Trofimova I; Dimtchev A; Jung M; Rosenthal D; Smulson M; Dritschilo A; Soldatenkov V
Cancer Res; 2002 Dec; 62(23):6879-83. PubMed ID: 12460902
[TBL] [Abstract][Full Text] [Related]
37. Prostate-specific amplification of expanded polyglutamine expression: a novel approach for cancer gene therapy.
Segawa T; Takebayashi H; Kakehi Y; Yoshida O; Narumiya S; Kakizuka A
Cancer Res; 1998 Jun; 58(11):2282-7. PubMed ID: 9622059
[TBL] [Abstract][Full Text] [Related]
38. Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interleukin-24 (IL-24) gene.
Saito Y; Miyahara R; Gopalan B; Litvak A; Inoue S; Shanker M; Branch CD; Mhashilkar AM; Roth JA; Chada S; Ramesh R
Cancer Gene Ther; 2005 Mar; 12(3):238-47. PubMed ID: 15578066
[TBL] [Abstract][Full Text] [Related]
39. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
[TBL] [Abstract][Full Text] [Related]
40. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]